title: Insulin-like growth factor binding protein 2: gene expression microarrays and the hypothesis-generation paradigm.
abstract: A major goal of modern medicine is to identify key genes and their products that are altered in the diseased state and to elucidate the molecular mechanisms underlying disease development, progression, and resistance to therapy. This is a daunting task given the exceptionally high complexity of the human genome. The paradigm for research has historically been hypothesis-driven despite the fact that the hypotheses under scrutiny often rest on tenuous subjective grounds or are derived from and dependent on chance observation. The imminent deciphering of the complete human genome, coupled with recent advances in high-throughput bioanalytical technology, has made possible a new paradigm in which data-based hypothesis-generation is the initial step in the investigative process, followed by hypothesis-testing. Genomics technologies are the primary source of the new hypothesis-generating capabilities that are now empowering biomedical researchers. The synergistic interaction between contemporary genomics technologies and the hypothesis-generation paradigm is well-illustrated by the discovery and subsequent ongoing study of the role of insulin-like growth factor binding protein 2 (IGFBP2) in human glioma biology. Using gene expression microarray technology, the IGFBP2 gene was recently found to be highly and differentially overexpressed in the most advanced grade of human glioma, glioblastoma. Based on this discovery, subsequent functional studies were initiated that suggest that IGFBP2 overexpression may contribute to the invasive nature of glioblastoma, and that IGFBP2 may exert its function via a newly identified novel binding protein. The IGFBP2 story is but one example of the power and potential of the new molecular methodologies that are transforming modern diagnostic and investigative neuropathology.
authors.affiliation: Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. wzhang@mdanderson.org
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
authors.forename: Hua
authors.initials: H
authors.lastname: Wang
authors.forename: Sonya W
authors.initials: SW
authors.lastname: Song
authors.forename: Gregory N
authors.initials: GN
authors.lastname: Fuller
mesh_terms: D001932:Brain Neoplasms / Q000235:genetics* / Q000473:pathology*; D004252:DNA Mutational Analysis / Q000379:methods* / Q000639:trends; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics*; D023281:Genomics / Q000639:trends; D005910:Glioma / Q000235:genetics / Q000473:pathology; D006801:Humans; D018971:Insulin-Like Growth Factor Binding Protein 2 / Q000235:genetics*; D007834:Lasers; D020411:Oligonucleotide Array Sequence Analysis / Q000639:trends*; D012107:Research Design / Q000639:trends*
chemical_list: D018971:Insulin-Like Growth Factor Binding Protein 2